A Prognostic DNA Methylation Signature for Stage I Non–Small-Cell Lung Cancer
Abstract
Non-small-cell lung cancer (NSCLC) is a tumor in which only small improvements in clinical outcome have been achieved. The issue is critical for stage I patients for whom there are no available biomarkers that indicate which high-risk patients should receive adjuvant chemotherapy. We aimed to find DNA methylation markers that could be helpful in this regard.A DNA methylation microarray that analyzes 450,000 CpG sites was used to study tumoral...
Paper Details
Title
A Prognostic DNA Methylation Signature for Stage I Non–Small-Cell Lung Cancer
Published Date
Nov 10, 2013
Journal
Volume
31
Issue
32
Pages
4140 - 4147
Citation AnalysisPro
You’ll need to upgrade your plan to Pro
Looking to understand the true influence of a researcher’s work across journals & affiliations?
- Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
- Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.
Notes
History